Date : 6th January 2011
Inno Bio Innovation Centre Sdn Bhd is a subsidiary company of Inno Bio Ventures Sdn Bhd which was established since March 2002, one of Ministry of Finance Incorporated Company, with a close affiliation with the Ministry of Science, Technology and Innovation.
Inno Biologics is part of the Boehringer Ingelheim CMO (Contract Manufacturing Organization) network, member of Massachusetts Institute of Technology- Centre of Biomedical Innovation (CBI) Biomanufacturing Alliance and strategic partners with CEVEC GmbH and CIMAB SA.
Inno Biologics has recently joined other forward-thinking companies as a member of MIT-Centre for Biomedical Innovation Biomanufacturing Alliance, as its show of support for collaborative efforts to foster innovation within the drug industry.
Inno Biologics signed an agreement to license technology from the Cuba’s Centre for Molecular Immunology (CIM) to reduce the human anti-mouse antibody (HAMA) response in patients receiving chimeric antibodies.
Inno Biologics received the BioNexus status in 2006 as one of the first wave leading biotechnology companies in Malaysia.
The Board of Directors of Inno Bio:
Ø Tan Sri Datuk Dr. Ahmad Zaharudin Idrus - Chairman Ø Datuk Dr Ahmed Tasir bin Lope Pihie - Director Ø Dato’ Dr. Mohd Nazlee Kamal - Director |
Bio Innovation Centre envisions a seam less integration of services for its partners in biotech manufacturing. Its unique lab-to-office design intends to create safe laboratory environment and secure workplace. For cost effective solutions, partners can have convenient access to Quality Management and Analytical laboratory and multiple Core Technology Facilities (CTF) such as: Proteomic, Genomics & Analytical Biochemistry, Small Scale API Biochemistry, Medicinal Chemistry, Bioinformatics and Clean Room. Other services provided are: contract research, humanization services, antibody development, cell banking, analytics, process development, protein expression, cell line, yield improvement scale up from non cGMP to cGMP and cGMP manufacturing.
In conclusion, Inno Bio is one of the great and the first wave leading biotechnology companies in Malaysia which provide contract, research and manufacturing services especially in antibody development, cell banking, protein expression, and cell line. The latest achievement of Inno Bio was Biospectrum-Emerging 2010 Awards from Singapore. This performance shows the capability and expertise of Inno Bio internationally and globally.
No comments:
Post a Comment